REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101. A total of 85 filers reported holding REGULUS THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $92,000 | +3.4% | 55,537 | +40.1% | 0.00% | – |
| Q4 2016 | $89,000 | -25.8% | 39,627 | +8.7% | 0.00% | – |
| Q3 2016 | $120,000 | +16.5% | 36,462 | +2.0% | 0.00% | – |
| Q2 2016 | $103,000 | -44.9% | 35,762 | +32.2% | 0.00% | -100.0% |
| Q1 2016 | $187,000 | -20.1% | 27,042 | +0.7% | 0.00% | 0.0% |
| Q4 2015 | $234,000 | +41.8% | 26,867 | +6.3% | 0.00% | 0.0% |
| Q3 2015 | $165,000 | -38.0% | 25,267 | +4.1% | 0.00% | 0.0% |
| Q2 2015 | $266,000 | +7.7% | 24,272 | +66.6% | 0.00% | 0.0% |
| Q1 2015 | $247,000 | +47.0% | 14,572 | +39.4% | 0.00% | – |
| Q4 2014 | $168,000 | +124.0% | 10,452 | -4.3% | 0.00% | – |
| Q3 2014 | $75,000 | -14.8% | 10,927 | 0.0% | 0.00% | – |
| Q2 2014 | $88,000 | – | 10,927 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 4,039,823 | $26,420,000 | 3.79% |
| Foresite Capital Management II, LLC | 1,750,269 | $11,447,000 | 3.48% |
| ARGONAUT CAPITAL MANAGEMENT CORP | 75,000 | $491,000 | 1.65% |
| Abingworth LLP | 327,350 | $2,138,000 | 1.25% |
| Trellus Management Company, LLC | 100,000 | $654,000 | 0.96% |
| Cormorant Asset Management, LP | 896,522 | $5,863,000 | 0.94% |
| DAFNA Capital Management LLC | 90,000 | $589,000 | 0.58% |
| ORACLE INVESTMENT MANAGEMENT INC | 749,064 | $4,898,000 | 0.50% |
| Foresite Capital Management II, LLC | 250,000 | $1,635,000 | 0.50% |
| Foresite Capital Management II, LLC | 250,000 | $1,635,000 | 0.50% |